THE DE PARYS GROUP
DE PARYS GROUP, 23 DE PARYS AVENUE, BEDFORDDM006
The percentage of patients with diabetes, on the register, with a diagnosis of nephropathy (clinical proteinuria) or micro-albuminuria who are currently treated with an ACE-I (or ARBs)
Indicator | Year | Numerator | Denominator | Ratio | Centile |
---|---|---|---|---|---|
DM 15 | 2005 | 37 | 49 | 75.5% | |
DM 15 | 2006 | 56 | 67 | 83.6% | |
DM 15 | 2007 | 83 | 92 | 90.2% | |
DM 15 | 2008 | 84 | 92 | 91.3% | |
DM 15 | 2009 | 94 | 107 | 87.9% | |
DM 15 | 2010 | 95 | 106 | 89.6% | |
DM 15 | 2011 | 103 | 109 | 94.5% | |
DM 15 | 2012 | 104 | 112 | 92.9% | |
DM 15 | 2013 | 116 | 134 | 86.6% | |
DM006 | 2014 | 124 | 124 | 100.0% | |
DM006 | 2015 | 115 | 118 | 97.5% | |
DM006 | 2016 | 116 | 119 | 97.5% | |
DM006 | 2017 | 166 | 169 | 98.2% | |
DM006 | 2018 | 162 | 164 | 98.8% | |
DM006 | 2019 | 359 | 365 | 98.4% | |
DM006 | 2020 | 390 | 404 | 96.5% | |
DM006 | 2021 | 409 | 416 | 98.3% | |
DM006 | 2022 | 387 | 469 | 82.5% | |
DM006 | 2023 | 368 | 437 | 84.2% |